About This Event

Abpro Holdings Inc (Nasdaq: ABP), a biotechnology company with the mission of improving the lives of those facing severe and life-threatening diseases with next-generation antibody therapies, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Miles Suk, Co-CEO and Chairman, Tony Eisenberg, Director of Abpro, and Jason Chryssicas, CFO of Atlantic Coastal, ring the Closing Bell.